These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 30346023

  • 1. Prevalence of and risk factors for abnormal vaginal flora and its association with adverse pregnancy outcomes in a rural district in north-east Bangladesh.
    Baqui AH, Lee ACC, Koffi AK, Khanam R, Mitra DK, Dasgupta SK, Uddin J, Ahmed P, Rafiqullah I, Rahman M, Quaiyum A, Koumans EH, Christian P, Saha SK, Mullany LC, Labrique A, MIST Study Team of the Projahnmo Study Group in Bangladesh.
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):309-319. PubMed ID: 30346023
    [Abstract] [Full Text] [Related]

  • 2. Screening and treatment of maternal genitourinary tract infections in early pregnancy to prevent preterm birth in rural Sylhet, Bangladesh: a cluster randomized trial.
    Lee AC, Quaiyum MA, Mullany LC, Mitra DK, Labrique A, Ahmed P, Uddin J, Rafiqullah I, DasGupta S, Mahmud A, Koumans EH, Christian P, Saha S, Baqui AH, Projahnmo Study Group.
    BMC Pregnancy Childbirth; 2015 Dec 07; 15():326. PubMed ID: 26643558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin.
    Ugwumadu A, Reid F, Hay P, Manyonda I.
    Obstet Gynecol; 2004 Jul 07; 104(1):114-9. PubMed ID: 15229009
    [Abstract] [Full Text] [Related]

  • 6. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.
    Lamont RF, Nhan-Chang CL, Sobel JD, Workowski K, Conde-Agudelo A, Romero R.
    Am J Obstet Gynecol; 2011 Sep 07; 205(3):177-90. PubMed ID: 22071048
    [Abstract] [Full Text] [Related]

  • 7. Screen-and-treat program by point-of-care of Atopobium vaginae and Gardnerella vaginalis in preventing preterm birth (AuTop trial): study protocol for a randomized controlled trial.
    Bretelle F, Fenollar F, Baumstarck K, Fortanier C, Cocallemen JF, Serazin V, Raoult D, Auquier P, Loubière S.
    Trials; 2015 Oct 19; 16():470. PubMed ID: 26482128
    [Abstract] [Full Text] [Related]

  • 8. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
    Rosenstein IJ, Morgan DJ, Lamont RF, Sheehan M, Doré CJ, Hay PE, Taylor-Robinson D.
    Infect Dis Obstet Gynecol; 2000 Oct 19; 8(3-4):158-65. PubMed ID: 10968599
    [Abstract] [Full Text] [Related]

  • 9. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.
    Ugwumadu A, Manyonda I, Reid F, Hay P.
    Lancet; 2003 Mar 22; 361(9362):983-8. PubMed ID: 12660054
    [Abstract] [Full Text] [Related]

  • 10. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Subtil D, Brabant G, Tilloy E, Devos P, Canis F, Fruchart A, Bissinger MC, Dugimont JC, Nolf C, Hacot C, Gautier S, Chantrel J, Jousse M, Desseauve D, Plennevaux JL, Delaeter C, Deghilage S, Personne A, Joyez E, Guinard E, Kipnis E, Faure K, Grandbastien B, Ancel PY, Goffinet F, Dessein R.
    Lancet; 2018 Nov 17; 392(10160):2171-2179. PubMed ID: 30322724
    [Abstract] [Full Text] [Related]

  • 11. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.
    McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R.
    Am J Obstet Gynecol; 1994 Apr 17; 170(4):1048-59; discussion 1059-60. PubMed ID: 8166188
    [Abstract] [Full Text] [Related]

  • 12. Bacterial vaginosis in pregnancy and early labour using Nugent scoring and the implication on foetal outcome.
    Sule-Odu AO, Oluwole AA, Akadri AA, Andu BA, Akiseku AK, Osinupebi OA, Lawal IA, Oritogun KS.
    Ghana Med J; 2020 Mar 17; 54(1):10-16. PubMed ID: 32863408
    [Abstract] [Full Text] [Related]

  • 13. Effect of population-based antenatal screening and treatment of genitourinary tract infections on birth outcomes in Sylhet, Bangladesh (MIST): a cluster-randomised clinical trial.
    Lee AC, Mullany LC, Quaiyum M, Mitra DK, Labrique A, Christian P, Ahmed P, Uddin J, Rafiqullah I, DasGupta S, Rahman M, Koumans EH, Ahmed S, Saha SK, Baqui AH, Projahnmo Study Group in Bangladesh.
    Lancet Glob Health; 2019 Jan 17; 7(1):e148-e159. PubMed ID: 30554751
    [Abstract] [Full Text] [Related]

  • 14. Effect of antibiotic exposure on Nugent score among pregnant women with and without bacterial vaginosis.
    Anderson B, Zhao Y, Andrews WW, Dudley DJ, Sibai B, Iams JD, Wapner RJ, Varner MW, Caritis SN, O'Sullivan MJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU).
    Obstet Gynecol; 2011 Apr 17; 117(4):844-849. PubMed ID: 21422854
    [Abstract] [Full Text] [Related]

  • 15. Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population.
    Krauss-Silva L, Almada-Horta A, Alves MB, Camacho KG, Moreira ME, Braga A.
    BMC Pregnancy Childbirth; 2014 Mar 19; 14():107. PubMed ID: 24641730
    [Abstract] [Full Text] [Related]

  • 16. Antibiotics for treating bacterial vaginosis in pregnancy.
    McDonald HM, Brocklehurst P, Gordon A.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD000262. PubMed ID: 17253447
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the Congo.
    Mulinganya G, De Vulder A, Bisimwa G, Boelens J, Claeys G, De Keyser K, De Vos D, Hendwa E, Kampara F, Kujirakwinja Y, Mongane J, Mubalama I, Vaneechoutte M, Callens S, Cools P.
    PLoS One; 2021 Jan 24; 16(10):e0257939. PubMed ID: 34695126
    [Abstract] [Full Text] [Related]

  • 18. The role of bacterial vaginosis, aerobic vaginitis, abnormal vaginal flora and the risk of preterm birth.
    Lamont RF, Taylor-Robinson D.
    BJOG; 2010 Jan 24; 117(1):119-20; author reply 120-1. PubMed ID: 20002381
    [No Abstract] [Full Text] [Related]

  • 19. Mycoplasma, bacterial vaginosis-associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort.
    Foxman B, Wen A, Srinivasan U, Goldberg D, Marrs CF, Owen J, Wing DA, Misra D.
    Am J Obstet Gynecol; 2014 Mar 24; 210(3):226.e1-7. PubMed ID: 24096128
    [Abstract] [Full Text] [Related]

  • 20. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.
    Kekki M, Kurki T, Pelkonen J, Kurkinen-Räty M, Cacciatore B, Paavonen J.
    Obstet Gynecol; 2001 May 24; 97(5 Pt 1):643-8. PubMed ID: 11339909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.